We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$613M
2
VTRS icon
Viatris
VTRS
+$608M
3
HON icon
Honeywell
HON
+$605M
4
PFGC icon
Performance Food Group
PFGC
+$166M
5
LYFT icon
Lyft
LYFT
+$162M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTUS
2226
DELISTED
Natus Medical Inc
NTUS
$13K ﹤0.01%
626
– –
ANAT
2227
DELISTED
American National Group, Inc. Common Stock
ANAT
$13K ﹤0.01%
133
– –
AKBA icon
2228
Akebia Therapeutics
AKBA
$327M
$12K ﹤0.01%
4,403
– –
OSG
2229
Octave Specialty Group
OSG
$252M
$12K ﹤0.01%
757
– –
CVM icon
2230
CEL-SCI Corp
CVM
$20.6M
$12K ﹤0.01%
34
– –
DRRX
2231
DELISTED
DURECT Corp
DRRX
$12K ﹤0.01%
558
– –
IHRT icon
2232
iHeartMedia
IHRT
$535M
$12K ﹤0.01%
889
– –
MBWM icon
2233
Mercantile Bank Corp
MBWM
$1.01B
$12K ﹤0.01%
425
– –
OMER icon
2234
Omeros
OMER
$709M
$12K ﹤0.01%
846
– –
XENE icon
2235
Xenon Pharmaceuticals
XENE
$6.32B
$12K ﹤0.01%
795
– –
BCEL
2236
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$12K ﹤0.01%
767
– –
AGM icon
2237
Federal Agricultural Mortgage
AGM
$2.27B
$11K ﹤0.01%
148
– –
AMRX icon
2238
Amneal Pharmaceuticals
AMRX
$5.72B
$11K ﹤0.01%
2,482
– –
APLT
2239
DELISTED
Applied Therapeutics
APLT
$11K ﹤0.01%
514
– –
NGNE icon
2240
Neurogene
NGNE
$696M
$11K ﹤0.01%
38
– –
NRC icon
2241
NRC Health Common Stock
NRC
$474M
$11K ﹤0.01%
250
– –
TRST
2242
Trustco Bank Corp NY
TRST
$977M
$11K ﹤0.01%
316
– –
VREX icon
2243
Varex Imaging
VREX
$460M
$11K ﹤0.01%
639
– –
QTTB icon
2244
Q32 Bio
QTTB
$450M
$11K ﹤0.01%
52
– –
TVRD
2245
Tvardi Therapeutics
TVRD
$23.5M
$11K ﹤0.01%
21
– –
BPFH
2246
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$11K ﹤0.01%
1,319
– –
BANC icon
2247
Banc of California
BANC
$3.28B
$10K ﹤0.01%
668
– –
BRSP
2248
BrightSpire Capital
BRSP
$681M
$10K ﹤0.01%
1,293
– –
CNOB icon
2249
Center Bancorp
CNOB
$1.63B
$10K ﹤0.01%
499
– –
CUE icon
2250
Cue Biopharma
CUE
$135M
$10K ﹤0.01%
28
– –
88 89
90
91 92

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.